Daughter of Johnson & Johnson COVID-19 Vaccine Executive Dies Suddenly Following Seizures

A tragic incident unfolded earlier this month when the young daughter of a Johnson & Johnson Covid-19 vaccine executive died suddenly following a bout of seizures.

According to her family, 10-year-old girl Kelsey Corinne Morand suffered a fatal brain injury following a seizure on July 3.

“Our 10 year old daughter Kelsey Morand passed away unexpectedly on July 3rd, 2023,” reads a fundraiser in memory of Kelsey seeking to enhance children’s services at a local soup kitchen. “She suffered a brain injury brought on by a seizure and the result was too severe.”

A friend of the family wrote in a Facebook post the girl was “in the pediatric ICU after an extreme seizure yesterday that resulted in her flatlining for 20 minutes. She has been intubated, and is continuing to have seizure.

Facebook screenshots that have been making the rounds on social media reveal that Mike, Kelsey’s father, held a senior position at Johnson & Johnson and was instrumental in developing the Covid-19 vaccine.

“Friends – Wanted to share a bit of gratitude,” reads one Oct. 16, 2020, post. “I just started a new role at Johnson & Johnson as Director of Channel Strategy for Vaccines. First objective is to support the successful launch of our COVID vaccine, and I am extremely proud to play a small role in this unprecedented challenge.”

A tragic Facebook update from Morand just earlier this month noted Kelsey had “passed away unexpectedly.”

It’s unclear if the child had received a Covid-19 vaccination, or if the seizures she suffered were in any way related to a vaccination.

In Oct. 2021 Johnson & Johnson began conducting Phase 2a trials on Covid jabs for adolescents aged 12 to 17 years of age, however, the FDA last month revoked J&J’s emergency use authorization, effectively putting a halt to the company’s Covid vaccine program.

While it was not mRNA-based, the J&J one-dose Covid jab became the subject of scrutiny following reports it was causing blood clots in patients.

SOURCES: JOHNSON & JOHNSON, BLOOMBERG, YALE MEDICINE